CoChat
Sign Up
Cited by 28Cervical Cancer and HPV ResearchVaccine Coverage and HesitancyAdolescent Sexual and Reproductive Health

Human papillomavirus (HPV) awareness and vaccine receptivity among Senegalese adolescents

Open access
Massey, Philip M., Boansi, Ruth K., Gipson, Jessica D., Adams, Rachel M., Riess, Helene, Dieng, Thierno, Prelip, Michael L., Glik, Deborah C.·2017·Tropical Medicine & International Health
DOI 10.1111/tmi.12798PMC PMC5205573
Open this paper in CoChat — free account

Abstract

Objective: To examine HPV vaccine awareness and receptivity among adolescents and young adults in Senegal. Methods: Participants from six high schools and five community centres across five regions of Senegal (n = 2286) completed a self‐administered questionnaire in October and November 2014. The study assessed HPV awareness and receptivity towards receiving the HPV vaccine. Multivariable logistic regression explored statistically significant relationships between the predictor variables and both outcomes. Results: Twenty‐seven percent had heard of HPV. Among those who had heard of HPV (n = 616), only 28% indicated willingness to vaccinate. Multivariable analysis showed that respondents from rural areas had 63% higher odds (95% CI: 1.24, 2.12) of having heard of HPV than those in urban areas. Respondents with fathers who had completed higher education had 41% higher odds (95% CI: 1.04, 1.92) of being aware of HPV (P < 0.05); however, every level of father's education (as compared to no education at all) was negatively associated with willingness to vaccinate. Respondents who had previously spoken to a healthcare professional about the HPV vaccine had 80% higher odds (95% CI: 1.16, 2.81) of willingness to vaccinate than those who did not speak to a provider about the vaccine. Conclusions: Healthcare providers and parents are important stakeholders in disseminating HPV vaccine information. Given the overall low levels of awareness, there is a great opportunity for public health communication efforts to craft health messaging and information in a way to maximise receptivity, outlining benefits and providing information on the minimal risks associated with the vaccine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/tmi.12798

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Senegal, awareness about HPV was greater among adolescents and parents living in rural areas than among urban ones.

    “The level of awareness about HPV in Senegal was also greater among adolescents and parents who were living in rural area than the urban ones. 27”

    From Human Papillomavirus Vaccine Acceptability among Parents of Adolescent Girls in a Rural Area, Mysore, India (2018) · cites this paper as [27]

    The Results (Predictors of willingness to get HPV vaccine) report that students who spent most of their lives in rural areas had higher odds of having heard of HPV than students who grew up in urban areas. The study does not report the same rural–urban comparison for parents; its Discussion describes parents as stakeholders in sharing vaccine information, not as surveyed respondents. The residence measure also concerns where students grew up, rather than necessarily where they currently lived. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

  • International research shows that even with increased awareness, factors such as vaccine cost, perceived necessity, and cultural sensitivity influence HPV vaccination decision-making.

    “These findings are consistent with international research, which has shown that even with increased awareness, factors such as vaccine cost, perceived necessity, and cultural sensitivity influence decision-making51.”

    From Barriers to HPV vaccination among adolescent girls in India: A scoping review (2026) · cites this paper as [51]

    The Results (page unavailable) show that only 28% of Senegalese adolescents who had heard of HPV were willing to be vaccinated. The Introduction and Conclusions (pages unavailable) discuss social and cultural factors affecting vaccine uptake. Our copy does not establish vaccine cost or perceived necessity as influences on decisions, and it does not show that awareness had increased over time. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 28

  1. [2]Awolude OA Morhason-Bello IO Denny LA Adewole I Human papillomavirus infection and related cancers in sub-saharan africa: Burden and tools for prevention Vaccine 2013 31 vii x Available from 10.1016/j.vaccine.2012.06.065 24331751 · DOI
  2. [3]El-Khatib Z Tota JE Kaufmann AM Progress on human papillomavirus (HPV) infection and cervical cancer prevention in sub-saharan africa: Highlights of the 27th international papillomavirus conference in berlin, 17–22 september 2001 J Epidemiol Glob Health 2012 2 2 99 102 10.1016/j.jegh.2012.04.001 23856425 PMC7320374 · DOI
  3. [4]Sankaranarayanan R Anorlu R Sangwa-Lugoma G Denny LA Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa Vaccine 2013 31 F47 F52 10.1016/j.vaccine.2012.06.066 24331747 · DOI
  4. [5]LaMontagne S Barge A Le TN Mugisha E Penny M Gandhi S Human papillomavirus vaccine delivery strategiest that acheieved high coverage in low- and middle-income countries Bull World Health Organ 2011 89 11 821 30B 10.2471/BLT.11.089862 22084528 PMC3209730 · DOI
  5. [9]Cutts FT Franceschi S Goldie S Castellsague X de Sanjose S Garnett G Human papillomavirus and hpv vaccines: a review Bull World Health Organ 2007 85 9 719 26 10.2471/BLT.06.038414 18026629 PMC2636411 · DOI
  6. [10]Kirby T FDA approves new upgraded Gardasil 9 Lancet Oncol 2015 16 e56 10.1016/S1470-2045(14)71191-X 25532625 · DOI
  7. [13]Monie A Hung C-F Roden R Wu T-C Cervarix™: a vaccine for the prevention of hpv 16, 18-associated cervical cancer Biologics 2008 2 1 107 13 10.2147/BTT.S1877 PMC2727782 19707432 · DOI
  8. [14]Gardasil® [human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant], Merck’s hpv vaccine, available to developing countries through UNICEF tender [press release] Whitehouse Station, NJ Business Wire 5 9 2013
  9. [16]GAVI funds vaccines to protect girls against cervical cancer [press release] Geneva GAVI 2 4 2013 Accessed 01 April 2016
  10. [18]Gilmour S Kanda M Kusumi E Tanimoto T Kami M Shibuya K HPV vaccination programme in Japan Lancet 2013 382 9894 768 Available from 10.1016/S0140-6736(13)61831-0 23993189 · DOI
  11. [19]Larson HJ Brocard P Garnett G The India hpv-vaccine suspension Lancet 2010 376 9741 572 3 Available from 10.1016/S0140-6736(10)60881-1 20728739 · DOI
  12. [20]Perlman S Wamai RG Bain PA Welty T Welty E Ogembo JG Knowledge and awareness of hpv vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review PLos One 2014 9 3 e90912 10.1371/journal.pone.0090912 24618636 PMC3949716 · DOI
  13. [22]Petrosky E Bocchini JA Hariri S Chesson H Curtis CR Saraiya M Use of 9-valent human papillomavirus (hpv) vaccine: updated hpv vaccination recommendations of the advisory committee on immunization practices MMWR 2015 64 11 300 304 25811679 PMC4584883
  14. [23]Glik D Massey P Gipson J Dieng T Rideau A Prelip M Health-related media use among youth audiences in senegal Health Promot Int 2016 31 1 73 82 10.1093/heapro/dau060 25113152 PMC4745615 · DOI
  15. [24]Nelson D Kreps G Hesse B Croyle R Willis G Arora N The health information national trends survey (HINTS): development, design, and dissemination J Health Commun 2004 9 5 443 60 10.1080/10810730490504233 15513791 · DOI
  16. [25]Neuhauser L Kreps G Rethinking communication in the e-health era J Health Psychol 2003 8 1 7 23 10.1177/1359105303008001426 22113897 · DOI
  17. [28]Anorlu RI Cervical cancer: the sub-Saharan African perspective Rreprod Health Matter 2008 16 32 41 9 10.1016/S0968-8080(08)32415-X 19027621 · DOI
  18. [29]Ylitalo KR Lee H Mehta NK Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the U.S. national immunization survey Am J Public Health 2013 103 1 164 9 10.2105/AJPH.2011.300600 22698055 PMC3518336 · DOI
  19. [30]Cunningham MS Skrastins E Fitzpatrick R Jinda P Oneko O Yeates K Cervical cancer screening and hpv vaccine acceptability among rural and urban women in Kilimanjaro region, Tanzania BMJ Open 2015 5 3 e005828-e 10.1136/bmjopen-2014-005828 PMC4360576 25757944 · DOI
  20. [31]Ports KA Reddy DM Rameshbabu A Barriers and facilitators to hpv vaccination: perspectives from Malawian women Women Health 2013 53 6 630 45 10.1080/03630242.2013.809046 23937733 PMC4681389 · DOI
  21. [32]Makwe CC Anorlu RI Odeyemi KA Human papillomavirus (hpv) infection and vaccines: knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria J Epidemiol Glob Health 2012 2 4 199 206 10.1016/j.jegh.2012.11.001 23856501 PMC7320323 · DOI
  22. [34]McCarey C Pirek D Tebeu PM Boulvain M Doh AS Petignat P Awareness of hpv and cervical cancer prevention among cameroonian healthcare workers BMC Womens Health 2011 11 1 45 10.1186/1472-6874-11-45 22008186 PMC3219551 · DOI
  23. [35]Remes P Selestine V Changalucha J Ross DA Wight D de Sanjose S A qualitative study of hpv vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania Vaccine 2012 30 36 5363 7 Available from 10.1016/j.vaccine.2012.06.025 22732428 PMC3409375 · DOI
  24. [36]Ugwu EO Obi SN Ezechukwu PC Okafor II Ugwu AO Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria Niger J Clin Pract 2013 16 2 249 52 10.4103/1119-3077.110141 23563471 · DOI
  25. [37]DiAngi YT Panozzo CA Ramogola-Masire D Steenhoff AP Brewer NT A cross-sectional study of hpv vaccine acceptability in Gaborone, Botswana PLos One 2011 6 10 e25481 10.1371/journal.pone.0025481 22039413 PMC3201944 · DOI
  26. [38]Kepka D Coronado GD Rodriguez HP Thompson B Evaluation of a radionovela to promote hpv vaccine awareness and knowledge among Hispanic parents J of Community Health 2011 36 6 957 965 21452030 PMC4065612
  27. [39]Hull PC Williams EA Khabele D Dean C Bond B Sanderson M HPV vaccine use among African American girls: qualitative formative research using a participatory social marketing approach Gynecol Oncol 2014 132 S13 S20 24491412 PMC3966189
  28. [40]Sood S Klassen A Cronin C Massey P Shefner-Rogers C Looking back and planning ahead: Examining global best practices in communication for inactivated polio vaccination introduction in rwanda Global Health Communication 2016 1 1 10 20 10.1080/23762004.2016.1161418 · DOI

Cited by

Sorted by citations

Authors
Massey, P. M., Boansi, R. K., Gipson, J. D., Adams, R. M., Riess, H., Dieng, T., Prelip, M. L., & Glik, D. C.
Affiliations
  • Drexel University (US)
  • University of California, Los Angeles (US)
  • Hôpital Aristide Le Dantec (SN)
Corresponding author
Massey, Philip M.
ORCID
Venue
Tropical Medicine & International Health
Publisher
Wiley
Published
2016-11-14
Volume
22
Issue
1
Pages
113-121
ISSN
  • 1360-2276 (ISSN-L)
  • 1365-3156
DOI
10.1111/tmi.12798
PMC
PMC5205573
OpenAlex
W2534137995
Cited by
28
References
0
Citations by year
2026: 2 · 2025: 5 · 2024: 6 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 3
FWCI
1.25
Type
journal article
Language
en
Open access
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations
  • Tropical Medicine & International Health (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
NIH-NICHD Fogarty Behavioral and Social Science (TW009043-01)
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Health Professions › General Health Professions › Adolescent Sexual and Reproductive Health
Keywords
human papillomavirus, HPV vaccine, vaccine awareness, adolescents, young adults, urban-rural differences, parental education, provider communication, public health communication, Senegal
MeSH terms
Adolescent, Awareness, Female, Humans, Health Knowledge, Attitudes, Practice, Male, Patient Acceptance of Health Care, Rural Population, Senegal, Socioeconomic Factors, Urban Population, Papillomavirus Infections, Papillomavirus Vaccines, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review